Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.

Keywords

Medicine, Histopathology, Breast cancer, Scintigraphy, Adverse effect

References

• The alpha v beta 3 integrin "vitronectin receptor".Michael A. Horton — 1997
• Human endothelial cells express integrin receptors on the luminal aspect of their membrane.G Conforti, Carmen Domı́nguez-Jiménez, Adriana Zanetti — 1992
• Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.Iraj Khalkhali, Javier Villanueva‐Meyer, S L Edell — 2000
• Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the LiteratureMoïshe Liberman, Fotini Sampalis, David S. Mulder — 2003
• Tumor angiogenesis: therapeutic implications.Louis M. Sherwood, Edith E. Parris, Judah Folkman — 1971
• Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingDorothy A. Sipkins, David A. Cheresh, Mahmood R. Kazemi — 1998
• Targeting tumor angiogenic vasculature using polymer-RGD conjugates.Amitava Mitra, Justin Mulholland, Anjan Nan — 2005
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.Peter C. Brooks, Richard A.F. Clark, David A. Cheresh — 1994
• Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDRoland Haubner, Wolfgang Weber, Ambros J. Beer — 2005
• Angiogenesis and apoptosis.Judah Folkman — 2003
• Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.Merry L. Lindsey, G. Patricia Escobar, Lawrence W. Dobrucki — 2006
• Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis.Melpomeni Fani, Dimitrios Psimadas, Christos Zikos — 2006
• Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.Bruce R. Line, Amitava Mitra, Anjan Nan — 2005
• 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinomaRimma Danielsson, Alejandro Sánchez-Crespo, A. Pegerfalk — 2003
• Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.Marcel L Janssen, Wim J.G. Oyen, Ingrid Dijkgraaf — 2002
• Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.Roland Haubner, H J Wester, Fred Burkhart — 2001
• Angiogenesis: basic pathophysiology and implications for disease.DC Felmeden — 2003
• Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.John Buscombe, Jarosław B. Ćwikła, B. Holloway — 2001
• Prone scintimammography in patients with suspicion of carcinoma of the breast.I Khalkhali, I Mena, E Jouanne — 1994

Cited by

• Preclinical Molecular Imaging of Tumor AngiogenesisLei Zhu, Gang Niu, Xuexun Fang — 2010
• Integrin Imaging with 99mTc-3PRGD2 SPECT/CT Shows High Specificity in the Diagnosis of Lymph Node Metastasis from Non-Small Cell Lung Cancer.Isabel Gamarra Rodríguez — 2016
• Molecular imaging and the failing heart: through the looking glass.Douglas L. Mann — 2009
• 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expressionZhanhong Wu, Zi-Bo Li, Weibo Cai — 2007
• Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritisChao Huang, Qing Zheng, Weibing Miao — 2015
• Elucidating the IGFBP2 signaling pathway in glioma development and progressionKristen M. Holmes — 2012
• Targeted Molecular Imaging of Angiogenesis in PET and SPECT: A ReviewMitchel R. Stacy, Mark W. Maxfield, Albert J. Sinusas — 2012
• Integrin αvβ3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter 68Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) LigandRakhee Vatsa, Priya Bhusari, Sunil Kumar — 2015
• Molecular breast imagingMichael K. O’Connor, Deborah J. Rhodes, Carrie B. Hruska — 2009
• 99mTc-3PRGD2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumabQingjie Ma, Kaiyin Min, Ting Wang — 2015
• Radiopharmaceutical development of radiolabelled peptidesMelpomeni Fani, Helmut R. Maëcke — 2012
• Imagerie de la néoangiogenèse en médecine nucléaireEmmanuel Deshayes, Vincent Dunet, C. Rüegg — 2012
• Metabolism in rats of NC100692, an RGD-peptide for imaging of angiogenesis.Line Roed, Inger Oulie, T Knüttel — 2008
• Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failureAbdul Mozid, Maria Holstensson, Tawfiq Choudhury — 2014
• Methods for 18F-labeling of RGD peptides: comparison of aminooxy [18F]fluorobenzaldehyde condensation with ‘click labeling’ using 2-[18F]fluoroethylazide, and S-alkylation with [18F]fluoropropanethiolMatthias Glaser, Magne Solbakken, David R. Turton — 2009
• Non-Invasive Imaging for Studying Anti-Angiogenic Therapy EffectsJosef Ehling, Twan Lammers, Fabian Kießling — 2013
• Molecular imaging of angiogenesis with SPECTIngrid Dijkgraaf, Otto C. Boerman — 2010
• The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide 18F-AH111585 in Healthy VolunteersBrian J. McParland, Matthew P. Miller, T J Spinks — 2008
• Molecular imaging targeting peptide receptors.Margret Schottelius, Hans‐Jürgen Wester — 2009
• Multimodality Imaging of Integrin αvβ3 ExpressionYin Zhang⋆, Yunan Yang, Weibo Cai — 2011

Related papers

• Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDRoland Haubner, Wolfgang Weber, Ambros J. Beer — 2005
• Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer PatientsLaura Kenny, R. Charles Coombes, Inger Oulie — 2008
• Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.Roland Haubner, H. J. Wester, Wolfgang Weber — 2001
• Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.Ambros J. Beer, Roland Haubner, Mario Sarbia — 2006
• Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.Ambros J. Beer, Roland Haubner, Michael Goebel — 2005
• Patterns of αvβ3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PETAmbros J. Beer, Markus Niemeyer, Janette Carlsen — 2008
• Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.Roland Haubner, Hans‐Jürgen Wester, Ute Reuning — 1999
• Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia.Jing Hua, Lawrence W. Dobrucki, Mehran M. Sadeghi — 2005
• [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.Roland Haubner, Bertrand Kühnast, Christian Mang — 2004
• An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the αv β 3-selective angiogenesis imaging agent 99mtc-nc100692Rimma Axelsson, Tore Bach‐Gansmo, Joan Castell‐Conesa — 2010